Latest Financial Risk Management News

Rox Resources has strategically purchased gold put options covering half of its forecast production at the Youanmi Gold Project for FY2028, locking in price protection while retaining upside exposure.

Bendigo and Adelaide Bank has been hit with a $50 million operational risk capital charge by APRA, while AUSTRAC launches an enforcement investigation into serious AML/CTF breaches. The bank commits to intensifying risk management efforts amid regulatory scrutiny.

Marimaca Copper Corp. reports a robust working capital position supported by recent capital raises, while managing a complex receivable linked to a liquidation process. The company remains well-positioned to fund operations over the next year but faces uncertainties beyond that horizon.

Commonwealth Bank of Australia reported a 33 basis point increase in its CET1 capital ratio for Q3 2025, driven by earnings growth despite a rise in risk-weighted assets. Liquidity and leverage metrics remain robust, underscoring the bank's resilient capital position.

OFX Group reports solid progress in migrating corporate clients to its new platform, OFX 2.0, despite a decline in net operating income driven by macroeconomic uncertainty. The fintech’s strategic product launches and client growth signal potential for recovery.

Metro Mining has delivered a striking half-year turnaround with a $119.8 million net profit, driven by record shipments, strong pricing, and significant foreign currency hedging gains.

Syntara Limited reported a significantly reduced loss for FY2025, driven by clinical progress and capital raises, while advancing its lead drug amsulostat with FDA Fast Track designation. The company also navigates ongoing payment disputes following the sale of its mannitol respiratory business.

Transmetro Corporation Limited reported robust financial results for FY25, with revenue and profit significantly up, underpinning a steady dividend payout.

SomnoMed Limited reported a record FY25 with $111.5 million revenue and a return to positive EBITDA, marking a milestone of over one million patients treated globally. The company secured FDA clearance for its Rest Assure® compliance tracking device and provided optimistic guidance for FY26.

Goodman Group delivered a robust FY25 performance, with operating profit rising 13% to $2.31 billion and a 9.8% increase in operating earnings per security. The company’s expanding data centre portfolio and strong capital position set the stage for continued growth.

Opyl Limited’s AI platform TrialKey has partnered with UK insurer Innovatrix to launch a pioneering parametric insurance product that protects biotech firms from the financial risks of clinical trial failures.

ANZ Group Holdings Limited delivered its strongest half-year revenue and profit to date, buoyed by the full contribution from Suncorp Bank and a robust capital position despite regulatory challenges.